Very excited that our paper on key use cases for AI to reduce the frequency of adverse drug events is just out in Lancet Digital, led by @AniaSyrowatka, part of our collaboration with @IBMWatsonHealth Lots of opportunity here! https://t.co/Ci5TfHptUc